Companies: 10,795·Total market cap: $144.5T

Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd.

GLMDNASDAQHealthcare● Active

$0.47

$-0.23(-32.57%)

Market Cap$2571403

P/E Ratio—

52W High$2.34

52W Low$0.411

Avg Volume3.0M

Open$0.59

Beta0.71

Net Income Financials Revenue

Galmed Pharmaceuticals Ltd. (GLMD) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

GLMD · net income · updated Jun 9, 2026

Core profitability metrics

GLMD · net income · margin · TTM · CAGR

Net income was −$10.3M for FY2025 (fiscal year ending 2025-12-31), down 37.1% year-over-year. Net profit margin was —.

FY2025 Net Income−$10.3M▼ -37.1% YoY

Trailing 12M (TTM)−$10.3Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-37.1%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · GLMD net income history · GLMD profit margin

Annual net income data

GLMD · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$10.3M▼ 37.1%—$0

FY2024Loss−$7.5M▼ 8.8%—$0

FY2023Loss−$6.9M▲ +61.3%—$0

FY2022Loss−$17.9M▲ +45.0%—$0

FY2021Loss−$32.5M▼ 12.8%—$0

Net income vs peers (Healthcare)

GLMD vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Galmed Pharmaceuticals Ltd.YOU

GLMD

−$10.3M-37.1%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Galmed Pharmaceuticals Ltd. (GLMD) reported net income of −$10.3M for FY2025 (fiscal year ending 2025-12-31), down 37.1% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Galmed Pharmaceuticals Ltd. has not yet achieved annual profitability based on available data (14 fiscal years). The company has reported net losses across all available periods.

Galmed Pharmaceuticals Ltd.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Galmed Pharmaceuticals Ltd. net worth" — the company's market capitalization is a separate figure from GLMD net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

GLMD net income · 4 questions

Galmed Pharmaceuticals Ltd. is not currently profitable on an annual basis. The company reported a net loss of $10.3M for FY2025.

is GLMD profitabledoes GLMD make a profitGLMD profitabilityGLMD profitable company

▸ Source: FMP /income-statement · GAAP · Galmed Pharmaceuticals Ltd. · Galmed Pharmaceuticals Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026